Total assets contracted 16% from $12.5B in 2024Q1 to $10.5B in 2026Q2, while D/E rose to 0.94 and cash fell to $217.7M, indicating strained liquidity and rising leverage.
Clarivate Plc (CLVT) balance sheet — 9-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 |
|---|
| Total Current Assets | 1.21B | 1.31B | 1.24B | 1.46B | 1.4B | 1.64B | 1.15B | 493.08M | 408.61M | 443.91M |
| Cash & Short-Term Investments | 217.7M | 329.2M | 295.2M | 370.7M | 348.8M | 587.61M | 257.73M | 76.13M | 25.57M | 53.19M |
| Cash Only | 217.7M | 329.2M | 295.2M | 370.7M | 348.8M | 587.61M | 257.73M | 76.13M | 25.57M | 53.19M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 827.9M | 821.7M | 798.3M | 908.3M | 872.1M | 906.43M | 737.73M | 333.86M | 331.3M | 317.81M |
| Days Sales Outstanding | 126.43 | 122.16 | 113.97 | 126.11 | 119.68 | 176.27 | 214.71 | 125.07 | 124.86 | 126.41 |
| Inventory | 0 | 0 | 0 | 0 | 97.4M | 0 | 0 | 0 | 31.03M | 52.76M |
| Days Inventory Outstanding | - | - | - | - | 37.27 | - | - | - | 28.56 | 48.85 |
| Other Current Assets | 168.6M | 64.9M | 65.2M | 94.7M | 76.9M | 66.65M | 93.83M | 42.38M | 31.13M | 44.52M |
| Total Non-Current Assets | 9.27B | 9.76B | 10.25B | 11.24B | 12.55B | 18.55B | 13.64B | 3.3B | 3.3B | 3.56B |
| Property, Plant & Equipment | 88.3M | 99.3M | 107.1M | 106.8M | 113.4M | 169.88M | 168.62M | 103.49M | 20.64M | 23.01M |
| Fixed Asset Turnover | 25.16x | 24.73x | 23.87x | 24.61x | 23.46x | 11.05x | 7.44x | 9.41x | 46.92x | 39.88x |
| Goodwill | 1.34B | 1.57B | 1.57B | 2.02B | 2.88B | 7.9B | 6.04B | 1.33B | 1.28B | 1.31B |
| Intangible Assets | 7.73B | 8.01B | 8.44B | 9.01B | 9.44B | 10.39B | 7.37B | 1.83B | 1.96B | 2.16B |
| Long-Term Investments | 21.8M | 1.8M | 14.7M | 17.7M | 47.2M | 1.96M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 86.5M | 66.3M | 67.5M | 43.1M | 50.7M | 48.75M | 31.33M | 18.63M | 26.56M | 60.03M |
| Total Assets | 10.49B | 11.07B | 11.49B | 12.71B | 13.94B | 20.18B | 14.79B | 3.79B | 3.71B | 4.01B |
| Asset Turnover | 0.22x | 0.22x | 0.22x | 0.21x | 0.19x | 0.09x | 0.08x | 0.26x | 0.26x | 0.23x |
| Asset Growth % | -23.45% | -3.66% | -9.57% | -8.88% | -30.91% | 36.46% | 290.11% | 2.2% | -7.38% | - |
| Total Current Liabilities | 1.44B | 1.57B | 1.43B | 1.6B | 1.56B | 1.9B | 1.42B | 651M | 643.71M | 661.07M |
| Accounts Payable | 152.9M | 150.6M | 124.5M | 144.1M | 101.4M | 129.22M | 82.04M | 26.46M | 38.42M | 60.76M |
| Days Payables Outstanding | 65.98 | 65.94 | 52.28 | 58.03 | 38.8 | 75.33 | 68.24 | 27.44 | 35.37 | 56.26 |
| Short-Term Debt | 18.3M | 101.5M | 20.6M | 24.4M | 26.7M | 62.75M | 28.6M | 9M | 60.34M | 45.34M |
| Deferred Revenue (Current) | 3.71B | 941.4M | 943.9M | 983.1M | 947.5M | 1.03B | 707.32M | 407.32M | 391.1M | 361.26M |
| Other Current Liabilities | 367.5M | 146.7M | -20.6M | 321.9M | 326.4M | 348.01M | 57.75M | 26.87M | 0 | 0 |
| Current Ratio | 0.85x | 0.84x | 0.87x | 0.91x | 0.89x | 0.86x | 0.81x | 0.76x | 0.63x | 0.67x |
| Quick Ratio | 0.85x | 0.84x | 0.87x | 0.91x | 0.83x | 0.86x | 0.81x | 0.76x | 0.59x | 0.59x |
| Cash Conversion Cycle | 60.45 | - | - | - | 118.15 | - | - | - | 118.06 | 119 |
| Total Non-Current Liabilities | 4.51B | 4.66B | 4.92B | 5.11B | 5.57B | 6.36B | 4.33B | 1.89B | 2.02B | 2.06B |
| Long-Term Debt | 4.24B | 4.32B | 4.52B | 4.72B | 4.97B | 5.46B | 3.46B | 1.63B | 1.93B | 1.97B |
| Capital Lease Obligations | 113.7M | 37.9M | 53.2M | 63.2M | 72.9M | 93.95M | 104.32M | 64.19M | 0 | 0 |
| Deferred Tax Liabilities | 889.5M | 212.1M | 273.3M | 249.6M | 316.1M | 380.06M | 367M | 48.55M | 43.23M | 51.79M |
| Other Non-Current Liabilities | 75.8M | 86.2M | 55.9M | 41.9M | 171.4M | 370.59M | 362.2M | 130.7M | 24.84M | 22.61M |
| Total Liabilities | 5.95B | 6.23B | 6.35B | 6.71B | 7.13B | 8.26B | 5.76B | 2.54B | 2.66B | 2.72B |
| Total Debt | 4.26B | 4.48B | 4.59B | 4.81B | 5.1B | 5.61B | 3.63B | 1.72B | 1.99B | 2.01B |
| Net Debt | 4.04B | 4.15B | 4.3B | 4.44B | 4.76B | 5.03B | 3.37B | 1.65B | 1.96B | 1.96B |
| Debt / Equity | 0.94x | 0.92x | 0.89x | 0.80x | 0.75x | 0.47x | 0.40x | 1.38x | 1.89x | 1.57x |
| Debt / EBITDA | 8.86x | 5.41x | 10.17x | - | - | 12.45x | 13.59x | 14.60x | 15.14x | 24.72x |
| Net Debt / EBITDA | 8.41x | 5.01x | 9.52x | - | - | 11.15x | 12.62x | 13.96x | 14.94x | 24.07x |
| Interest Coverage | -0.33x | 0.65x | -0.95x | -2.45x | -13.76x | -0.02x | -2.16x | -0.58x | -0.81x | -1.06x |
| Total Equity | 4.54B | 4.84B | 5.14B | 5.99B | 6.81B | 11.93B | 9.03B | 1.25B | 1.05B | 1.29B |
| Equity Growth % | -30.7% | -5.76% | -14.24% | -12.04% | -42.88% | 32% | 623.59% | 18.85% | -18.31% | - |
| Book Value per Share | 7.10 | 7.19 | 7.41 | 8.92 | 10.04 | 18.61 | 21.08 | 4.56 | 3.44 | 4.21 |
| Total Shareholders' Equity | 4.54B | 4.84B | 5.14B | 5.99B | 6.81B | 11.93B | 9.03B | 1.25B | 1.05B | 1.29B |
| Common Stock | 12.82B | 12.81B | 12.98B | 11.74B | 11.74B | 11.83B | 9.99B | 2.14B | 16K | 16K |
| Retained Earnings | -7.82B | -7.51B | -7.31B | -6.65B | -5.66B | -1.6B | -1.25B | -890.89M | -632.26M | -390.1M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | -16.96M | -196.04M | 0 | 0 | 0 |
| Accumulated OCI | -454.3M | -453.1M | -526.3M | -495.3M | -665.9M | 326.75M | 492.38M | -4.88M | 5.36M | 13.98M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying CLVT stock.
As of 2025, Clarivate Plc (CLVT) had total assets of $11.07B including $1.31B in current assets.
Clarivate Plc (CLVT) carries total debt of $4.48B, offset by $329.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Clarivate Plc (CLVT) has total shareholders' equity (book value) of $4.84B ($7.19 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Clarivate Plc (CLVT) reported a current ratio of 0.84x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Persistent losses and high leverage
Metrics are mathematically derived from official filings.
Shrinking Balance Sheet Amid Losses
Total assets contracted from $12.5B in 2024Q1 to $10.5B in 2026Q2, a 16% decline, while equity fell from $5.9B to $4.5B, as per reported figures, indicating ongoing balance sheet erosion.
The sequential decline in total assets and equity reflects both the impact of persistent net losses and potential asset impairments, as goodwill dropped from $2.0B to $1.3B over the period. This trend suggests that the company's asset base is shrinking faster than debt reduction, which may signal deteriorating business quality. Investors should monitor whether this contraction stabilizes or accelerates, as it could further pressure leverage ratios.
Leverage Creeps Higher as Debt Persists
Total debt remained near $4.3B while equity fell, pushing D/E from 0.81 in 2024Q1 to 0.94 in 2026Q2, as reported in financial statements, indicating rising leverage despite modest debt paydown.
Although total debt declined by roughly $500M over the period, the faster erosion of equity has increased the debt-to-equity ratio, suggesting that deleveraging is not keeping pace with balance sheet shrinkage. The absolute debt level remains substantial relative to cash and equity, implying that refinancing risk and interest burden could become more pronounced if operating losses persist. The company's ability to service this debt depends on sustaining positive operating cash flow, which has been volatile.
Goodwill Impairments Signal Acquisition Risk
Goodwill fell from $2.0B in 2024Q1 to $1.3B in 2026Q2, a 35% reduction, as per reported figures, suggesting significant impairments that may reflect overpayment for past acquisitions.
The sharp decline in goodwill, alongside a shrinking asset base, indicates that the company has recognized impairments, likely due to lower expected future cash flows from acquired businesses. This raises questions about the quality of the asset base and the sustainability of the business model, as the remaining $1.3B goodwill still represents a meaningful portion of total assets. Investors should assess whether further impairments are likely, which could erode equity further.
Retained Losses Deplete Equity Buffer
Accumulated deficit deepened from -$6.7B in 2024Q1 to -$7.8B in 2026Q2, as reported in SEC filings, reflecting cumulative net losses that have consumed over $1B of equity.
The widening negative retained earnings is a direct consequence of persistent net losses, which have exceeded $1.1B over the past ten quarters. This depletion of equity reduces the cushion for creditors and may limit financial flexibility, as the company cannot rely on retained earnings to fund operations or investments. The lack of dividend payments and negative share repurchases in recent quarters suggests that capital is being conserved, but the equity base remains under pressure.
Liquidity Tightens as Cash Dwindles
Cash fell from $361.8M in 2024Q1 to $217.7M in 2026Q2, while the current ratio slipped to 0.85, as per reported figures, indicating a shrinking liquidity buffer against short-term obligations.
The current ratio below 1.0 suggests that current liabilities exceed current assets, which may indicate potential difficulty in meeting short-term obligations without relying on cash flow or external financing. Cash levels have declined by nearly 40% over the period, and with operating cash flow volatile, the company's ability to absorb shocks appears limited. This tight liquidity position warrants close monitoring, especially if revenue continues to decline.
Deferred Revenue Masks Underlying Weakness
Deferred revenue fluctuated between $875.7M and $1.0B over the past ten quarters, as per financial statements, but its stability may obscure the true pace of revenue recognition and customer churn.
While deferred revenue has remained relatively stable, this could be misleading if the composition is shifting toward shorter-term contracts or if renewals are weakening. The stability might mask a decline in new business, as the income statement shows revenue contraction. Investors should examine the quality of deferred revenue and whether it is being drawn down faster than it is being replenished, which could signal future revenue pressure.